NCT02025933

Brief Summary

It has previously been seen that increased fish intake improves the metabolic health of overweight and obese adults, and animal protein improved metabolic health of obese rats. In this project the investigators will investigate whether increased intake of fish or meat improve metabolic health in children aged 9-12 years as well when replacing processed food. The hypothesis is that increased intake of unprocessed fish or meat will improve metabolic health in children as measured by glucose tolerance, lipid metabolism and inflammatory markers.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
25

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Aug 2014

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 17, 2013

Completed
15 days until next milestone

First Posted

Study publicly available on registry

January 1, 2014

Completed
7 months until next milestone

Study Start

First participant enrolled

August 1, 2014

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2015

Completed
Last Updated

May 24, 2016

Status Verified

May 1, 2016

Enrollment Period

1 year

First QC Date

December 17, 2013

Last Update Submit

May 22, 2016

Conditions

Keywords

ChildrenAge 9-12 yearsOverweight (iso-BMI > 25)

Outcome Measures

Primary Outcomes (1)

  • Changes in metabolic status (glucose, lipids, inflammation)

    We will investigate any changes in the metabolic status by analyzing parameters affected by changes in glucose homeostasis, lipid metabolism and inflammation.

    Baseline and end of intervention period (12 weeks)

Secondary Outcomes (1)

  • Body composition

    Baseline and end of intervention (12 weeks)

Study Arms (3)

Salmon Group

Participants will eat 75 - 150 grams of salmon for dinner, three times a week for 12 weeks.

Other: Salmon Group

Cod Group

Participants will eat 75-150 grams of cod for dinner, three times a week for 12 weeks.

Other: Cod Group

Meat Group

Participants will eat 75-150 grams of mixed meat for dinner, three times a week for 12 weeks.

Other: Meat Group

Interventions

The children are advised to eat at least 75g of salmon per serving, but no more than 150g

Salmon Group

The children are advised to eat at least 75g of cod per serving, but no more than 150g

Cod Group

The children are advised to eat at least 75g of meat per serving, but no more than 150g

Meat Group

Eligibility Criteria

Age9 Years - 12 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodProbability Sample
Study Population

Cildren aged 9-12 years are invited to participate in the study. The children must be healthy and not use prescription medications that affects lipid metabolism, glucose regulation or the immunesystem.

You may qualify if:

  • overweight (iso-BMI \> 25)
  • years
  • healthy

You may not qualify if:

  • diagnosed diseases such as diabetes, CVD, intestinal diseases, arthritis
  • prescription medications affecting the metabolism of glucose, lipids or the immune system
  • use of supplements containing long chain n-3 fatty acids
  • high intake of fish
  • food allergy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Bergen

Bergen, 5021, Norway

Location

Biospecimen

Retention: SAMPLES WITH DNA

Whole blood for DNA analysis

MeSH Terms

Conditions

Overweight

Condition Hierarchy (Ancestors)

OvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Oddrun A Gudbrandsen, PhD

    University of Bergen

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Researcher

Study Record Dates

First Submitted

December 17, 2013

First Posted

January 1, 2014

Study Start

August 1, 2014

Primary Completion

August 1, 2015

Study Completion

August 1, 2015

Last Updated

May 24, 2016

Record last verified: 2016-05

Locations